DMP updates STA submission guidance

DMP has updated its guideline and submission template for single technology assessments (STA) of pharmaceuticals in Norway.

What is included

• The guideline and template were updated as of July 2026.

• DMP clarified its requirements for “must” and “should” criteria.

• The submission template was updated to match the guideline.

Read more at https://www.dmp.no/en/public-funding-and-pricing/health-technology-assessments/medicines/submission-of-documentation-for-single-technology-assessment-of-pharmaceuticals